Moffitt logo

Articles related to Immunotherapy

CART-lab-640.jpg

TIL Immunotherapy Offers Promising Results in Metastatic Non-Small Cell Lung Cancer

A group of investigators at Moffitt Cancer Center initiated a trial to determine if non-small cell lung cancer patients could have response to TIL therapy Read More


Breast Cells

Combining Immunotherapy in Triple Negative Breast Cancer Treatment

Responses have been seen in some patients with triple-negative breast cancer (TNBC), signaling a potential role for immunotherapy in this tumor type. Read More


Pam-Griffith-LATTE.jpg

Immunotherapy Clinical Trial Brought Renewed Hope To Lung Cancer Patient

My husband and I celebrated our 50th wedding anniversary last year and know without a doubt that I would not be alive today if we had not sought treatment at Moffitt Cancer Center. Read More


lung-cancer-research-640.jpg

Moffitt’s Top Research Developments of 2017: Novel Combination Approach to Lung Cancer Wins Moffitt a Stand Up To Cancer Grant

The second one on the list of Moffitt research developments involves a grant to study how immunotherapy can change the way the cancer center is treating lung cancer. Read More


Locke-research-lab.jpg

Moffitt’s Top Research Developments of 2017: CAR T Therapy Tested, Commercially Available at Moffitt

The first one on the list of Moffitt's top research developments for 2017 is the FDA approval of CAR T therapy for certain aggressive types of adult lymphoma. Read More


CART-Cell-Illustration-640.jpg

Moffitt Treats First U.S. Patient with Newly FDA-Approved CAR T Therapy

Moffitt has treated the first U.S. adult lymphoma patient with a therapy formerly available only through clinical trials. Read More


CART-teaser.jpeg

Infographic: How CAR T Therapy Works to Fight Cancer

CAR T therapy, a groundbreaking new treatment, utilizes the body’s own immune system to fight cancer. Read More


CART-lab-640.jpg

What is CAR T Therapy?

Dr. Frederick Locke, vice chair of the Department of Blood and Marrow Transplant and Cellular Immunotherapy, answers some frequently asked questions about CAR T cell therapy. Read More


DrFredLocke-CART-640.jpg

CAR T Cancer Therapy a ‘Huge Breakthrough’ for Patients with Lymphoma

Moffitt patients with an aggressive type of lymphoma were among the first to benefit in clinical trials of a groundbreaking therapy. Read More


Abate-Daga-Spotlight-640.jpg

Research Spotlight: Dr. Abate-Daga Discusses the Progress of Immunotherapy

Dr. Daniel Abate-Daga's research is focused on the development of T cell-based immunotherapies for the treatment of cancer. Read More


Locke-blog.jpg

Dr. Locke: CAR-T Cell Therapy a 'Revolution in Cancer Care'

Dr. Locke, the principal investigator for a new experimental immunotherapy called CAR T-cell therapy, talks about the breakthroughs with this type of treatment. Read More


COMMUNITY OF COURAGE

STORIES TO INSPIRE YOU ON YOUR JOURNEY THROUGH CANCER